ID4 and ovarian cancer: In this regard, Ren and colleagues synthesized a complex delivery system containing the cyclic nonapeptide LyP-1 (CGNKRTRGC)-siRNA targeting GFP (siGFP) to evaluate the applicability of ID4 as a therapeutic target of ovarian cancer.